Cladribine alters immune cell surface molecules for adhesion and costimulation: Further insights to the mode of action in multiple sclerosis

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

Cladribine (CLAD) is a deoxyadenosine analogue prodrug which is given in multiple sclerosis (MS) as two short oral treatment courses 12 months apart. Reconstitution of adaptive immune function following selective immune cell depletion is the presumed mode of action. In this exploratory study, we investigated the impact of CLAD tablets on immune cell surface molecules for adhesion (CAMs) and costimulation (CoSs) in people with MS (pwMS). We studied 18 pwMS who started treatment with CLAD and 10 healthy controls (HCs). Peripheral blood mononuclear cells were collected at baseline and every 3 months throughout a 24-month period. We analysed ICAM-1, LFA-1, CD28, HLADR, CD154, CD44, VLA-4 (CD49d/CD29), PSGL-1 and PD-1 with re-gard to their expression on B and T cells (T helper (Th) and cytotoxic T cells (cT)) and surface density (mean fluorescence intensity, MFI) by flow cytometry. The targeted analysis of CAM and CoS on the surface of immune cells in pwMS revealed a higher percentage of ICAM-1 (B cells, Th, cT), LFA-1 (B cells, cT), HLADR (B cells, cT), CD28 (cT) and CD154 (Th). In pwMS, we found lower frequencies of Th and cT cells expressing PSGL-1 and B cells for the inhibitory signal PD-1, whereas the surface expression of LFA-1 on cT and of HLADR on B cells was denser. Twenty-four months after the first CLAD cycle, the frequencies of B cells expressing CD44, CD29 and CD49d were lower compared with the baseline, together with decreased densities of ICAM-1, CD44 and HLADR. The rate of CD154 expressing Th cells dropped at 12 months. For cT, no changes were seen for frequency or density. Immune reconstitution by oral CLAD was associated with modification of the pro-migra-tory and-inflammatory surface patterns of CAMs and CoSs in immune cell subsets. This observa-tion pertains primarily to B cells, which are key cells underlying MS pathogenesis.

References Powered by Scopus

The immunological synapse: A molecular machine controlling T cell activation

2673Citations
N/AReaders
Get full text

Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin

1615Citations
N/AReaders
Get full text

CD40 and CD154 in cell-mediated immunity

1371Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumorassociated macrophages

22Citations
N/AReaders
Get full text

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety

17Citations
N/AReaders
Get full text

Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting

7Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Moser, T., Hoepner, L., Schwenker, K., Seiberl, M., Feige, J., Akgün, K., … Sellner, J. (2021). Cladribine alters immune cell surface molecules for adhesion and costimulation: Further insights to the mode of action in multiple sclerosis. Cells, 10(11). https://doi.org/10.3390/cells10113116

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

50%

Researcher 3

50%

Readers' Discipline

Tooltip

Medicine and Dentistry 4

50%

Biochemistry, Genetics and Molecular Bi... 2

25%

Neuroscience 1

13%

Agricultural and Biological Sciences 1

13%

Save time finding and organizing research with Mendeley

Sign up for free